What is the current Price Target for the Olema Pharmaceuticals Inc stock?

The average Olema Pharmaceuticals Inc target price is $36.72. This is 346.44% higher than the current stock price. The highest price target is 653.19%, the lowest is 121.03%. 12 Analysts have issued a price target Olema Pharmaceuticals Inc 2027 .

How high will the Olema Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Olema Pharmaceuticals Inc stock will rise. The performance of stocks, including the Olema Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Olema Pharmaceuticals Inc stock today?

The performance of Olema Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Olema Pharmaceuticals Inc stock fall?

The decline in Olema Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Olema Pharmaceuticals Inc Forecast, price target & analysts

$8.23

0.54%

Nasdaq, Oct 02, 04:00 pm EDT. Closed.

ISIN

US68062P1066

Symbol

OLMA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Olema Pharmaceuticals Inc Target price 2026 - Analyst rating & recommendation

Olema Pharmaceuticals Inc Classifications & Recommendation

Buy

89%

Hold

11%

Olema Pharmaceuticals Inc Price Target

Target Price	$36.72
Price	$8.23
Potential	346.44% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target Olema Pharmaceuticals Inc 2027 . The average Olema Pharmaceuticals Inc target price is $36.72. This is 346.44% register free of charge higher than the current stock price. The highest price target is $61.95 653.19% register free of charge , the lowest is $18.18 121.03% register free of charge .
	A rating was issued by 18 analysts: 16 Analysts recommend Olema Pharmaceuticals Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Olema Pharmaceuticals Inc stock has an average upside potential 2027 of 346.44% register free of charge . Most analysts recommend the Olema Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.87	-2.49
	15.00%	33.16%
P/E		negative

13 Analysts have issued a Olema Pharmaceuticals Inc forecast for earnings per share. The average Olema Pharmaceuticals Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.87	15.00%
2026	$-2.49 33.16% unlock
2027	$-2.72 9.24% unlock
2028	$-2.29 15.81% unlock
2029	$-2.21 3.49% unlock
2030	$-1.69 23.53% unlock
2031	$-1.77 4.73% unlock
2032	$-0.51 71.19% unlock

Current	-4.22	26.38%
2026	-3.31 21.52% unlock
2027	-3.02 8.76% unlock
2028	-3.60 19.21% unlock
2029	-3.72 3.33% unlock
2030	-4.87 30.91% unlock

Olema Pharmaceuticals Inc...

Current Olema Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Stifel	Locked ➜ Locked	Locked	Sep 14 2026
JP Morgan	Locked ➜ Locked	Locked	Aug 13 2026
Citigroup	Locked ➜ Locked	Locked	Aug 11 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 11 2026
Guggenheim	Locked ➜ Locked	Locked	May 13 2026
Wolfe Research	Locked ➜ Locked	Locked	Mar 27 2026
JP Morgan	Locked ➜ Locked	Locked	Mar 18 2026

Analyst Rating	Date
Locked Stifel: Locked ➜ Locked	Sep 14 2026
Locked JP Morgan: Locked ➜ Locked	Aug 13 2026
Locked Citigroup: Locked ➜ Locked	Aug 11 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 11 2026
Locked Guggenheim: Locked ➜ Locked	May 13 2026
Locked Wolfe Research: Locked ➜ Locked	Mar 27 2026
Locked JP Morgan: Locked ➜ Locked	Mar 18 2026

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 81.89%

Rheinmetall 70.55%

Tencent Holdings Ltd. 61.28%

Adyen 56.67%

Uber Technologies 51.26%

BYD 50.30%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now